Manufacturer record
Shiva Biogenetic Laboratories Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
7 batches manufactured by Shiva Biogenetic Laboratories Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between July 2022 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: FMT26015SL, Montelukast Sodium and Levocetirizine Hydrochloride Tablets IP (exp Mar 2028). LUCKNOW, Uttar Pradesh (state lab) found it not of standard quality: The sample does not conform to IP in respect of Dissolution. Listed in the September 2026 alert.
Records by type
7 records linked to Shiva Biogenetic Laboratories Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Montelukast Sodium and Levocetirizine Hydrochloride Tablets IP | Batch FMT26015SLMfg Apr 2026 · Exp Mar 2028 | The sample does not conform to IP in respect of DissolutionDissolution | LUCKNOW, Uttar PradeshState lab | Sep 2026 |
| Metronidazole Tablets IP 400 mg | Batch MET23027SLMfg May 2025 · Exp Apr 2027 | DissolutionDissolution | SDT&RL, BhubaneswarState lab | Mar 2026 |
| Rabeprazole Sodium & Domperidone SR Capsules (RABALKEM- DSR) | Batch RKBC22064 SMfg Dec 2022 · Exp Nov 2024 | Assay of RabeprazoleAssay | CDL KolkataCDSCO lab | Oct 2024 |
| ALCIFLOX 500 (Ciprofloxacin Tablets I.P.) | Batch ACT22004SLMfg Feb 2022 · Exp Jan 2025 | DissolutionDissolution | RDTL GuwahatiState lab | Mar 2023 |
| PAMAGIN-P (Diclofenac Sodium and Paracetamol Tablets IP) | Batch PPT21010SLMfg Jul 2021 · Exp Jun 2024 | DissolutionDissolution | RDTL GuwahatiState lab | Oct 2022 |
| ALCIFLOX� 500 (Ciprofloxacin Tablets IP) | Batch ACT21015SLMfg Oct 2021 · Exp Sep 2024 | DissolutionDissolution | RDTL GuwahatiState lab | Sep 2022 |
| Ciprofloxacin Tablets IP | Batch AFT21002SLMfg Jul 2021 · Exp Jun 2024 | DissolutionDissolution | RDTL GuwahatiState lab | Jul 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.